184 related articles for article (PubMed ID: 18061949)
1. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
Bahler DW; Hartung L; Hill S; Bowen GM; Vonderheid EC
Cytometry B Clin Cytom; 2008 May; 74(3):156-62. PubMed ID: 18061949
[TBL] [Abstract][Full Text] [Related]
2. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules.
Lundell R; Hartung L; Hill S; Perkins SL; Bahler DW
Am J Clin Pathol; 2005 Dec; 124(6):937-46. PubMed ID: 16416744
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
[TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
5. Absolute CD3+ CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in Sézary syndrome.
Bouaziz JD; Remtoula N; Bensussan A; Marie-Cardine A; Bagot M
Br J Dermatol; 2010 Jan; 162(1):123-8. PubMed ID: 19681856
[TBL] [Abstract][Full Text] [Related]
6. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
7. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.
Poszepczynska-Guigné E; Schiavon V; D'Incan M; Echchakir H; Musette P; Ortonne N; Boumsell L; Moretta A; Bensussan A; Bagot M
J Invest Dermatol; 2004 Mar; 122(3):820-3. PubMed ID: 15086570
[TBL] [Abstract][Full Text] [Related]
8. CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides.
Ortonne N; Le Gouvello S; Tabak R; Marie-Cardine A; Setiao J; Berrehar F; Nghe-Tang A; Martin N; Bagot M; Bensussan A
Exp Dermatol; 2012 Jun; 21(6):461-3. PubMed ID: 22621189
[TBL] [Abstract][Full Text] [Related]
9. Significance of circulating T-cell clones in Sezary syndrome.
Ortonne N; Huet D; Gaudez C; Marie-Cardine A; Schiavon V; Bagot M; Musette P; Bensussan A
Blood; 2006 May; 107(10):4030-8. PubMed ID: 16418328
[TBL] [Abstract][Full Text] [Related]
10. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.
Ortonne N; Le Gouvello S; Mansour H; Poillet C; Martin N; Delfau-Larue MH; Leroy K; Farcet JP; Bagot M; Bensussan A
J Invest Dermatol; 2008 Feb; 128(2):465-72. PubMed ID: 17703174
[TBL] [Abstract][Full Text] [Related]
11. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
Rappl G; Muche JM; Abken H; Sterry W; Tilgen W; Ugurel S; Reinhold U
J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
[TBL] [Abstract][Full Text] [Related]
12. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood.
Jones D; Dang NH; Duvic M; Washington LT; Huh YO
Am J Clin Pathol; 2001 Jun; 115(6):885-92. PubMed ID: 11392886
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
[TBL] [Abstract][Full Text] [Related]
14. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric features of angioimmunoblastic T-cell lymphoma.
Chen W; Kesler MV; Karandikar NJ; McKenna RW; Kroft SH
Cytometry B Clin Cytom; 2006 May; 70(3):142-8. PubMed ID: 16572417
[TBL] [Abstract][Full Text] [Related]
16. CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome.
Vergnolle I; Douat-Beyries C; Boulinguez S; Rieu JB; Vial JP; Baracou R; Boudot S; Cazeneuve A; Chaugne S; Durand M; Estival S; Lablanche N; Nicolau-Travers ML; Tournier E; Lamant L; Vergez F
Blood Adv; 2022 Mar; 6(6):1813-1825. PubMed ID: 34570200
[TBL] [Abstract][Full Text] [Related]
17. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
[TBL] [Abstract][Full Text] [Related]
18. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome.
Hristov AC; Vonderheid EC; Borowitz MJ
Am J Clin Pathol; 2011 Dec; 136(6):944-53. PubMed ID: 22095381
[TBL] [Abstract][Full Text] [Related]
19. Utility of CD26 in flow cytometric immunophenotyping of T-cell lymphomas in tissue and body fluid specimens.
Pierson DM; Jones D; Muzzafar T; Kersh MJ; Challagundla P; Medeiros LJ; Jorgensen JL
Cytometry B Clin Cytom; 2008 Nov; 74(6):341-8. PubMed ID: 18727078
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
Fierro MT; Novelli M; Quaglino P; Comessatti A; Fava P; Ortoncelli M; Ponti R; Bernengo MG
Dermatology; 2008; 216(3):213-21. PubMed ID: 18182812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]